Thermo Fisher Scientific Stock News

Strs Ohio lowered its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 6.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 278,941 shares of the medical research companys stock after selling 18,763 shares during the quarter. Thermo Fisher Scientific accounts for 0.6% of Strs []

PGGM Investments trimmed its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 15.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 288,148 shares of the medical research companys stock after selling 51,044 shares during the period. Thermo Fisher Scientific makes up approximately 0.8% of PGGM []

HAMPTON, N.H. , Dec. 9, 2021 /PRNewswire/ -- Novalis LifeSciences LLC, an investment and advisory firm for the Life Science industry, announced today that is has raised $300M in capital for its second fund Novalis LifeSciences Investments II, LP. In addition, Paul M. Meister has joined the firm as partner. Novalis LifeSciences is focused on highly innovative Life Science companies. On the occasion of closing the second fund, Marijn E. Dekkers, founder and chairman, said: "This second fund will continue with the investment strategy of Fund I. It will invest in 10-15 companies that are commercializing breakthrough technologies in various segments of the Life Science industry." These segments include biopharma therapeutics, life science tools, genomics, synthetic biology, molecular diagnostics, and agricultural biotechnology all areas with huge unmet needs and exciting opportunities for investors. Some key portfolio companies of Fund I are Ginkgo Bioworks, Cerevel Therapeutics, Decipher Biosciences, Quanterix, and Biotalys, all of which recently became public companies or were acquired.

Morris Capital Advisors LLC reduced its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 3.4% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 7,794 shares of the medical research companys stock after selling 273 shares during the period. Thermo Fisher Scientific []

WALTHAM, Mass., Dec. 8, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc. (Nasdaq: PPD), a leading global provider of clinical research

DUBLIN--(BUSINESS WIRE)--The "3D Cell Culture Technologies Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com''s offering. The global 3D cell culture technologies market is expected to grow from $1.63 billion in 2020 to $1.88 billion in 2021 at a compound annual growth rate (CAGR) of 15.3%. The market is expected to reach $4.23 billion in 2025 at a CAGR of 22.5%. Major players in the 3D cell culture technologies market are Nano3D Biosci

Great Diamond Partners LLC acquired a new stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) in the 3rd quarter, HoldingsChannel reports. The institutional investor acquired 922 shares of the medical research company’s stock, valued at approximately $526,000. A number of other hedge funds and other institutional investors have also recently made changes to their […]

Vaccine refrigerators square measure wont to store vaccines to shield them from deterioration at the temperature necessary. Vaccines square measure very temperature-sensitive, and their deterioration may end up from variations within the storage temperature. The global immunogen white goods market is

The Global Biobanking Equipment Market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2021-2028). The research presents a complete assessment of the market and contains Future trend, Current

Biotechnology Services Market 2021 report helps the clients to take business decisions and to understand strategies of major players in the industry. The report also calls for market- driven results deriving feasibility studies for client needs. Market Insights Reports ensures

Strategic Advisors LLC lifted its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 0.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,262 shares of the medical research companys stock after purchasing an additional 68 shares during the quarter. Thermo Fisher Scientific []

Thermo Fisher Scientific Inc. (NYSE:TMO) has been given an average recommendation of Buy by the twenty analysts that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, fourteen have assigned a buy recommendation and one has given a strong buy []

Valley Brook Capital Group Inc. cut its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 0.7% during the third quarter, Holdings Channel reports. The institutional investor owned 4,015 shares of the medical research companys stock after selling 30 shares during the period. Thermo Fisher Scientific makes up about 2.3% of Valley Brook Capital Group Inc.s []

The Bovine Serum Albumin is used in a variety of laboratory applications including its function as a protein concentration standard, its function as a cell nutrient, and its ability to stabilize enzymes during restriction digest. May be harmful if absorbed through